Division of Cardiovascular Medicine, Henry Ford Health System, Detroit, Michigan (Drs Keteyian and Brawner); Centers for Disease Control and Prevention, Atlanta, Georgia (Drs Jackson, Ritchey, and Sperling, Mr Chang, and Ms Wall); Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan (Dr Brawner); Divisions of Geriatrics and Cardiology, University of Pittsburgh and the VA Pittsburgh GRECC, Pittsburgh, Pennsylvania (Dr Forman); Division of Cardiovascular Diseases, University of Michigan, Ann Arbor (Dr Sukul); and Center for Heart Disease Prevention, Emory University School of Medicine, Atlanta, Georgia (Dr Sperling).
J Cardiopulm Rehabil Prev. 2022 Jul 1;42(4):235-245. doi: 10.1097/HCR.0000000000000675. Epub 2022 Feb 8.
This study updates cardiac rehabilitation (CR) utilization data in a cohort of Medicare beneficiaries hospitalized for CR-eligible events in 2017, including stratification by select patient demographics and state of residence.
We identified Medicare fee-for-service beneficiaries who experienced a CR-eligible event and assessed their CR participation (≥1 CR sessions in 365 d), engagement, and completion (≥36 sessions) rates through September 7, 2019. Measures were assessed overall, by beneficiary characteristics and state of residence, and by primary (myocardial infarction; coronary artery bypass surgery; heart valve repair/replacement; percutaneous coronary intervention; or heart/heart-lung transplant) and secondary (angina; heart failure) qualifying event type.
In 2017, 412 080 Medicare beneficiaries had a primary CR-eligible event and 28.6% completed ≥1 session of CR within 365 d after discharge from a qualifying event. Among beneficiaries who completed ≥1 CR session, the mean total number of sessions was 25 ± 12 and 27.6% completed ≥36 sessions. Nebraska had the highest enrollment rate (56.1%), with four other states also achieving an enrollment rate >50% and 23 states falling below the overall rate for the United States.
The absolute enrollment, engagement, and program completion rates remain low among Medicare beneficiaries, indicating that many patients did not benefit or fully benefit from a class I guideline-recommended therapy. Additional research and continued widespread adoption of successful enrollment and engagement initiatives are needed, especially among identified populations.
本研究更新了医疗保险受益人群中 2017 年符合心脏康复(CR)条件的事件住院患者队列中的 CR 利用率数据,包括按选定患者人口统计学特征和居住州进行分层。
我们确定了经历过 CR 合格事件的医疗保险收费服务受益人群,并通过 2019 年 9 月 7 日评估了他们的 CR 参与(365 天内至少进行 1 次 CR 治疗)、参与度和完成度(≥36 次)率。评估指标包括总体、按受益人群特征和居住州以及按主要(心肌梗死;冠状动脉旁路移植术;心脏瓣膜修复/置换;经皮冠状动脉介入治疗;或心肺移植)和次要(心绞痛;心力衰竭)合格事件类型进行评估。
2017 年,412080 名医疗保险受益人群发生了主要的 CR 合格事件,其中 28.6%的人在出院后 365 天内完成了至少 1 次 CR 治疗。在完成至少 1 次 CR 治疗的受益人群中,平均总治疗次数为 25±12,27.6%的人完成了≥36 次治疗。内布拉斯加州的入组率最高(56.1%),其他四个州的入组率也超过 50%,而 23 个州的入组率低于美国的总体水平。
医疗保险受益人群中的绝对入组率、参与度和方案完成率仍然较低,这表明许多患者没有从 I 类指南推荐的治疗中获益或未完全获益。需要进一步研究并持续广泛采用成功的入组和参与计划,特别是针对确定的人群。